Illumina and PacBio Sequencing of Human and Mouse DNA and RNA

Scope Summary

The Mechanistic Studies Division (MSD) of Health Canada’s Environmental Health Research and Science Bureau investigates the pathways by which physical, chemical and microbiological agents can cause adverse health effects. To determine how chemical substances cause DNA damage that can lead to illnesses like cancer or inherited diseases, MSD requires high-throughput genome sequencing services utilizing Illumina and Pacific Biosciences (PacBio) platforms. The primary objective of this contract is to secure long-term high-quality sequencing services for pre-prepared DNA libraries and genomic DNA and/or RNA utilizing Illumina or PacBio Revio platforms for the full duration of projects funded until up to 2030-2031. This requirement encompasses the sequencing of multiple mouse and human error-corrected next-generation sequencing (ecNGS) DNA libraries, genomic DNA and/or RNA samples in direct support of four distinct research projects. These projects are distributed across the Division and funded through three separate programs. Collectively, they employ advanced genomic technologies to support public health protection by identifying environmental mutagens, evaluating occupational hazards,

Bid Readiness Checklist

• 1. Portal Registration & Eligibility Mandatory
  Confirm active supplier account on the issuing portal to submit bids to buyer "Department of Health (HC)" (Canada).
  Suggested Evidence: SAP Ariba Supplier ID / Procurement Business Number (PBN)
• 2. Submission Deadline & Format Mandatory
  Finalize pricing and compliance attachments at least 24 hours ahead of Closes 2026-12-10.
  Suggested Evidence: Signed Cover Form, Mandatory Returnables & Complete File Upload
• 3. Delivery Methodology & References Mandatory
  Provide a clear work plan, deliverable schedule, named key personnel, and 2–3 relevant client references.
  Suggested Evidence: Methodology Narrative, CVs & Case Studies
• 4. Commercial Pricing Schedule Mandatory
  Structure transparent itemized fixed or T&M rate pricing aligned with notice deliverables (ceiling not disclosed in notice).
  Suggested Evidence: Itemized Pricing Table, Rate Card & Scope Assumptions